| Application no. and date | 01925028.1 (espacenet) (Federated) (European Patent Register), 20010413 | | Patent/reg. no. and date | DK/EP 1278543, 20120919 | | Publication date | 20030129 | | Priority no. and date | US 550082, 20000414, US 748960, 20001227 | | EP pub. no. and date |
EP 1278543 20030129 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco CA 94080-4990, US,
Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka-shi, Osaka 541-0045, JP | | Applicant ref. no. | P50800DK01 | | Inventor | ALLISON, David, Edward, 1285 Oak Grove Avenue, Apt. 9
Burlingame, CA 94010, US,
FOX, Judith, A., 1531 Golden Gate Avenue
San Francisco, CA 94115, US,
BRETTMAN, Lee, R., 183 Greystone Lane
Sudbury, MA 01776, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/52 (2006.01) , A61K 31/57 (2006.01) , A61K 31/60 (2006.01) , A61K 31/635 (2006.01) , A61K 39/395 (2006.01) , A61P 37/06 (2006.01) | | Title | ANTISTOF DER BINDER ALFA4BETA7-INTEGRIN OG DETS ANVENDELSE TIL AT BEHANDLE INFLAMMATORISK TARMSYGDOM | | Int. application no. | US2001012234 | | Int. publication no. | WO2001078779 | | Related patent (certificate) | CA 2014 00060 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
